Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antibiotic cement bead pouch is a wound management strategy in which non-absorbable beads made from polymethyl methacrylate (PMMA) bone cement are mixed with powdered antibiotics and placed into an open wound or dead space. The beads are then sealed within the wound using an occlusive dressing to create a "pouch." This technique delivers high local concentrations of antibiotics directly to the site of infection or contamination while minimizing systemic toxicity. The most commonly used antibiotics are vancomycin and aminoglycosides (such as gentamicin or tobramycin), chosen for their broad spectrum and heat stability during PMMA polymerization. The primary indications include management of open fractures, chronic osteomyelitis, infected joint prostheses, and other musculoskeletal infections where dead space needs to be filled and infection controlled. The mechanism involves local elution of antibiotics from the PMMA matrix over several days to weeks, preventing bacterial growth and biofilm formation in avascular areas that may not be reached by systemic therapy[1][3][4][5][6]. After the risk period has passed or definitive closure is possible, the non-absorbable beads must be surgically removed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on antibiotic cement bead pouch.